Lymphoma, Non Hodgkin Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Not yet recruiting
  • Cancer
  • +21 more
  • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
  • (no location specified)
2021-11-12
Nov 12, 2021
N
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Recruiting
  • Lymphoma, Non-Hodgkin
  • +9 more
  • NKX019
  • Denver, Colorado
  • +4 more
2021-11-16
Nov 16, 2021
N
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
Recruiting
  • Acute Lymphoid Leukemia
  • +4 more
  • CD19/CD22 CAR T-Cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-11-16
Nov 16, 2021
C
A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)
Recruiting
  • Lymphoma, Non-Hodgkin
  • Santa Monica, California
  • +37 more
2021-11-15
Nov 15, 2021
B
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Copanlisib (BAY80-6946)
  • +7 more
  • Chandler, Arizona
  • +200 more
2021-11-12
Nov 12, 2021
E
Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
Recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Miami, Florida
  • +1 more
2021-11-12
Nov 12, 2021
N
Tissue Collection for Studies of Lymph Cancer
Recruiting
  • Hodgkin Disease
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-11-11
    Nov 11, 2021
    H
    A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of RO7227166 in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab Administered in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
    Recruiting
    • Lymphoma, Non-Hodgkin
    • Melbourne, Victoria, Australia
    • +11 more
    2021-11-10
    Nov 10, 2021
    M
    Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
    Recruiting
    • Hodgkin Disease
    • +2 more
    • pembrolizumab
    • Favezelimab
    • Gilbert, Arizona
    • +24 more
    2021-11-11
    Nov 11, 2021
    C
    A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Rituximab in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
    Recruiting
    • Lymphoma, Non-Hodgkin
    • Orange, California
    • +31 more
    2021-11-05
    Nov 5, 2021
    C
    Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Edmonton, Alberta, Canada
    • +9 more
    2021-11-08
    Nov 8, 2021
    J
    A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
    Recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Lymphoma, Non-Hodgkin
    • Houston, Texas
    • +32 more
    2021-11-08
    Nov 8, 2021
    J
    A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
    Recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Lymphoma, Non-Hodgkin
    • Duarte, California
    • +46 more
    2021-11-04
    Nov 4, 2021
    J
    A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Recruiting
    • Lymphoma, Non-Hodgkin
    • Chronic Lymphocytic Leukemia
    • New York, New York
    • +32 more
    2021-11-04
    Nov 4, 2021
    J
    A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Recruiting
    • Lymphoma, Non-Hodgkin
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • New York, New York
    • +15 more
    2021-11-04
    Nov 4, 2021
    J
    A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
    Recruiting
    • Lymphoma, Non-Hodgkin
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Birmingham, Alabama
    • +34 more
    2021-11-04
    Nov 4, 2021
    N
    Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
    Completed
    • Leukemia
    • +3 more
      • Bethesda, Maryland
        National Cancer Institute (NCI), 9000 Rockville Pike
      2021-11-02
      Nov 2, 2021
      N
      A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma - 1996
      Completed
      • Lymphoma, Non-Hodgkin
      • HIV Infections
      • Bleomycin sulfate
      • +9 more
      • Los Angeles, California
      • +21 more
      2021-10-26
      Oct 26, 2021
      N
      Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members - 1990
      Completed
      • Lymphoma, Non-Hodgkin
      • HIV Infections
      • Bleomycin sulfate
      • +9 more
      • Los Angeles, California
      • +13 more
      2021-10-27
      Oct 27, 2021
      N
      Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma - 1991
      Completed
      • Lymphoma, Non-Hodgkin
      • HIV Infections
      • Bleomycin sulfate
      • +8 more
      • Los Angeles, California
        USC CRS
      2021-10-26
      Oct 26, 2021
      M
      CAR-37 T Cells In Hematologic Malignancies
      Recruiting
      • Hematologic Malignancy
      • +5 more
      • CAR-37 T cells
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      2021-10-28
      Oct 28, 2021
      N
      Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) - 2013
      Completed
      Has Results
      • Lymphoma, B-Cell
      • +2 more
      • Autologous transplantation using rituxan/BEAM
      • Autologous transplantation using Bexxar/BEAM
      • New Haven, Connecticut
      • +35 more
      2021-10-21
      Oct 21, 2021
      C
      CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
      Recruiting
      • Lymphoma, Non-Hodgkin
      • +6 more
      • CB-010
      • +2 more
      • La Jolla, California
      • +4 more
      2021-10-28
      Oct 28, 2021
      N
      The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer - 1990
      Terminated
      • Lymphoma, Non-Hodgkin
      • HIV Infections
      • New Orleans, Louisiana
        Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU
      2021-10-27
      Oct 27, 2021
      C
      A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapsed/Refractory DLBCL and iNHL.
      Active, not recruiting
      • Lymphoma, Large B-Cell, Diffuse
      • Lymphoma, Non-Hodgkin
      • Borddeaux Cedex, France
      • +7 more
      2021-10-25
      Oct 25, 2021